RHUMBLINE ADVISERS

Position in QNRX — Quoin Pharmaceuticals Ltd.

CIK 1115418 BOSTON, MA

Position in QNRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$11,286

+$1,248 QoQ

Shares Held

2,332

+53.3% QoQ

Ownership

0.116%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#17

of 19 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. QNRX ranks #308 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,286	2,332	+53.3%	Shares	Sole	2026-08-12
2026-03-31	$10,038	1,521	-8.7%	Shares	Sole	2026-05-12
2025-12-31	$24,040	1,666	+37.7%	Shares	Sole	2026-02-13
2025-09-30	$8,699	1,210	-2.6%	Shares	Sole	2025-11-06
2025-06-30	$11,463	1,242	-97.0%	Shares	Sole	2025-08-12
2025-03-31	$9,349	41,741	+73.0%	Shares	Sole	2025-05-29
2024-12-31	$15,706	24,126	+16.1%	Shares	Sole	2025-05-29
2024-09-30	$10,247	20,786	+40.5%	Shares	Sole	2024-11-12
2024-06-30	$8,578	14,791	+289.3%	Shares	Sole	2024-08-01
2024-03-31	$3,608	3,799	+257.4%	Shares	Sole	2024-05-09
2023-12-31	$5,213	1,063	+17.1%	Shares	Sole	2024-02-08
2023-09-30	$3,767	908	-89.7%	Shares	Sole	2023-11-09
2023-06-30	$4,414	8,829	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.